诺舒阻抗控制子宫内膜切除系统治疗异常子宫出血120例临床分析

2018-04-08 09:50:18熊夏思
中国现代医生 2018年4期

熊夏思

[摘要] 目的 探讨诺舒(NovaSure)阻抗控制子宫内膜切除系统治疗异常子宫出血的有效性、安全性及推广价值。方法 选取2015年1月~2017年4月本院诊断为异常子宫出血患者120例,所有患者采用诺舒阻抗控制系统行子宫内膜切除术,术后1、3、6 个月门诊随访,观察疗效及并发症。 结果 120例患者均完成手术,诺舒治疗时间48~126 s,平均(84.1±19.2)s,术中出血5~15 mL,平均(9.5±0.7)mL。术后1、3、6个月的有效率分别为99%(118/120)、97%(116/120)和95%(114/120);闭经率分别为67.5%(81/120)、61.7%(74/120)和57.5%(69/120)。术中及术后均未出现明显并发症。结论 诺舒治疗异常子宫出血具有安全、有效、治疗时间短、操作简单等优点,近期疗效确切。

[关键词] 诺舒;子宫内膜切除;异常子宫出血;月经过多

[中图分类号] R713.4 [文献标识码] A [文章编号] 1673-9701(2018)04-0008-04

[Abstract] Objective To investigate the efficacy, safety and promotion value of NovaSure Resistance and Control System for endometrial exision in the treatment of abnormal uterine bleeding. Methods From January 2015 to April 2017,120 patients with abnormal uterine bleeding who were diagnosed in our hospital were given endometrial exision by NovaSure Resistance and Control System. The patients were given follow-up visit one, three and six months after the surgery. The efficacy and complications were observed. Results 120 cases completed the surgery. The treatment time of NovaSure was 48-126 s, The average was(84.1±19.2)s, and the intraoperative bleeding were 5-15 mL, with the average of (9.5±0.7) mL. The effective rates at 1, 3 and 6 months after surgery were 99%(118/120), 97%(116/120) and 95%(114/120) respectively. The rate of amenorrhea was 67.5%(81/120), 61.7%(74/120) and 57.5%(69/120) respectively. There was no obvious complications during and after the surgery. Conclusion NovaSure in the treatment of abnormal uterine bleeding is safe and effective.

[Key words] NovaSure; Endometrial exision; Abnormal uterine bleeding; Menometrorrhagia

异常子宫出血(abnormal uterine bleeding,AUB)是指与正常月经的周期、频率及经期持续时间、出血量等不同的来自子宫腔的异常出血。AUB是妇科内分泌门诊最常见的病种,常表现为月经量多、周期紊乱或出血时间长,进而产生贫血、感染等一系列后果,严重影响女性的身体健康及生活质量。对于异常子宫出血患者采取及时有效的治疗至关重要[1]。近些年随着微创技术的不断发展,子宫内膜去除术(endometrialablation,EA)由于其微创、操作简单、安全、有效等优点,得到妇科临床医师及患者的充分肯定,广泛运用于无生育要求的AUB患者中。诺舒(NovaSure)阻抗控制子宫内膜切除系统属于第2代EA,在国外已有十余年的应用历史。我国在2010年上市以來,陆续在各大城市开展应用。本研究选择2015年1月~2017年4月在本院接受诺舒治疗的120例异常子宫出血患者,近期临床疗效确切,现报道如下。……

登录APP查看全文